Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Mutation Ub globular domain-binding residue BL1 activates USP12. 1 / 1

| 1

➶

eidos

"Finally , consistent with the expected substrate-induced interactions between Ub and BL1 of USP12 in all forms , mutation of a Ub globular domain-binding residue on BL1 , Y264 , compromised the ability of both UAF1 and WDR20 to activate USP12 for Ub-AMC hydrolysis ( Figures 6D , 6E , and S5F ) ."

27373336

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...